1Li C, Bapat B, Alman BA. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis. Am J Pathol, 1998,153:709-714.
2Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis(desmoid tumor). Oncogene,1999,18:6615-6620.
3Saito T, Oda Y, Kawaguchi K, et al. Possible association between higher 13-catenin mRNA expression and mutated β-catenin in sporadic desmoid tumors: real-time semiquantitative assay by TaqMan plolymerase chain reaction. Lab Invest,2002,82:97-103.
4Denys H,Jadidizadeh A, Amini Nik S,et al. Identification of IGFBP-6 as a significantly downregulatied gene by beta-catenin in desmoid tumors. Oncogene ,2004,23:654-664.
5Olmeda D, Castel S, Vilaro S, et al. β-catenin regulation during the cycle: implications in G2/M and apoptosis. Mol Bio Cell,2003,14:2844-2860.
6Forus A, Weghuis DO, Smeets D, et al. Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer,1995,14:8-14.
7Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol, 1998,152 : 1107-1123.
8Tolg C, Poon R, Fodde R, et al. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis(desmoid tumor). Oncogene,2003 ,22 :6873-6882.
9Miettinen M. Desmoid-type fibromatosis (aggressive fibromatosis ).In: Miettinen M, ed. Dignostic soft tissue pathology. New York:Churchill Livingstone, 2003. 162-164.
10Goldblum J, Fletcher JA. Desmoid-type fibromatosis. In : Fletcher CD, Unni KK, Mertens F, eds. World Health Organization classification of tumors : pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press,2002.83-84.
